American Century Companies Inc Mirati Therapeutics, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$41.99 - $62.38 $281,542 - $418,257	6,705 New	6,705 $393,000
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $424,089 - $691,814	15,255 Added 101.14%	30,338 $1.32 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $320,978 - $439,669	8,884 Added 143.31%	15,083 $544,000
Q1 2023 May 11, 2023	BUY	$36.54 - $54.26 $10,450 - $15,518	286 Added 4.84%	6,199 $230,000
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $104,743 - $250,297	2,538 Added 75.2%	5,913 $267,000
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $200,812 - $292,612	3,375 New	3,375 $236,000
Q1 2022 May 11, 2022	SELL	$75.82 - $150.97 $134,504 - $267,820	-1,774 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$132.01 - $190.29 $47,919 - $69,075	363 Added 25.73%	1,774 $260,000
Q3 2021 Nov 10, 2021	BUY	$132.13 - $177.45 $21,537 - $28,924	163 Added 13.06%	1,411 $250,000
Q2 2021 Aug 05, 2021	SELL	$144.0 - $179.73 $8.72 Million - $10.9 Million	-60,537 Reduced 97.98%	1,248 $202,000
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $97,894 - $136,511	-616 Reduced 0.99%	61,785 $10.6 Million
Q4 2020 Feb 12, 2021	SELL	$162.05 - $240.27 $384,706 - $570,400	-2,374 Reduced 3.66%	62,401 $13.7 Million
Q3 2020 Nov 13, 2020	BUY	$113.26 - $167.27 $379,987 - $561,190	3,355 Added 5.46%	64,775 $10.8 Million
Q2 2020 Aug 13, 2020	BUY	$72.01 - $120.39 $4.42 Million - $7.39 Million	61,420 New	61,420 $7.01 Million
Q1 2020 May 14, 2020	SELL	$69.78 - $116.21 $3.01 Million - $5.02 Million	-43,197 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$70.76 - $128.86 $1.3 Million - $2.37 Million	18,390 Added 74.13%	43,197 $5.57 Million
Q3 2019 Nov 13, 2019	BUY	$77.91 - $109.6 $111,722 - $157,166	1,434 Added 6.14%	24,807 $1.93 Million
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $4,342 - $7,643	-73 Reduced 0.31%	23,373 $2.41 Million
Q1 2019 May 14, 2019	BUY	$43.65 - $78.95 $1.02 Million - $1.85 Million	23,446 New	23,446 $0

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account